Purchase of MALDI Biotyper
Forecast overview
- Subagency
- FDA
- NAICS
- 541990
- Program office
- HFP ACQUISITION
This is to replace the current Bruker biotyper system in the SA lab, which is no longer serviceable. MALDI-TOF MS technology is used for rapid bacterial identification, and its application to Clostridium botulinum involves identifying the bacterium and its neurotoxin.
Related federal terms
- NAICS — North American Industry Classification System
Acquisition timeline
- Last verified on RFPCapture
- 2026-08-31
- Estimated solicitation
- 4/2026 (agency estimate)
- Estimated award
- 6/2026 (agency estimate)
- Expected period of performance end
- 6/2026 (agency estimate)
Market context
- NAICS market
- NAICS 541990
- Active contractors in this market
- 5 with relevant federal experience
Contractors with relevant federal experience
Action links
Track this forecast in CaptureIQ
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31